| scholarly article | Q13442814 |
| P50 | author | Ranjan Preet | Q56233437 |
| P2093 | author name string | Chanakya Nath Kundu | |
| Dipon Das | |||
| Purusottam Mohapatra | |||
| Shakti Ranjan Satapathy | |||
| P2860 | cites work | Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes | Q23757358 |
| Second pathway for completion of human DNA base excision-repair: reconstitution with purified proteins and requirement for DNase IV (FEN1). | Q24532243 | ||
| Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer | Q27860681 | ||
| Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing | Q28140019 | ||
| 5-Fluorouracil: mechanisms of action and clinical strategies | Q28201937 | ||
| Cell-cycle checkpoints and cancer | Q28293996 | ||
| Cancer chemopreventive activity of resveratrol, a natural product derived from grapes | Q28300555 | ||
| Autophagy interplay with apoptosis and cell cycle regulation in the growth inhibiting effect of resveratrol in glioma cells | Q28478548 | ||
| Enzymes and reactions at the eukaryotic DNA replication fork | Q28610363 | ||
| Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer | Q29616236 | ||
| Bcl-XL small interfering RNA suppresses the proliferation of 5-fluorouracil-resistant human colon cancer cells | Q33212894 | ||
| The prosurvival role of autophagy in Resveratrol-induced cytotoxicity in human U251 glioma cells | Q33476510 | ||
| PARP inhibitors: its role in treatment of cancer | Q33579740 | ||
| Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer | Q33913953 | ||
| Brain tumor and Gliadel wafer treatment | Q34165378 | ||
| Cancer statistics, 1991. | Q35009044 | ||
| Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). | Q35147828 | ||
| Hypersensitivity phenotypes associated with genetic and synthetic inhibitor-induced base excision repair deficiency | Q35876447 | ||
| Structure and mechanism of DNA polymerase Beta. | Q36389634 | ||
| Targeting checkpoint kinase 1 in cancer therapeutics | Q36778499 | ||
| Participation of DNA repair in the response to 5-fluorouracil | Q37114275 | ||
| DNA damage detection and repair pathways--recent advances with inhibitors of checkpoint kinases in cancer therapy | Q37204585 | ||
| DNA alkylation by the haloethylnitrosoureas: nature of modifications produced and their enzymatic repair or removal | Q37984292 | ||
| p53-dependent transcriptional regulation of the APC promoter in colon cancer cells treated with DNA alkylating agents | Q38302465 | ||
| Cerivastatin enhances the cytotoxicity of 5-fluorouracil on chemosensitive and resistant colorectal cancer cell lines | Q38360942 | ||
| Resveratrol induces apoptosis via ROS-triggered autophagy in human colon cancer cells | Q39417628 | ||
| Quinacrine has anticancer activity in breast cancer cells through inhibition of topoisomerase activity | Q39547659 | ||
| Resveratrol induces apoptosis in breast cancer cells by E2F1-mediated up-regulation of ASPP1. | Q39561350 | ||
| Combination of arsenic trioxide and BCNU synergistically triggers redox-mediated autophagic cell death in human solid tumors | Q39697126 | ||
| Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model | Q39736902 | ||
| Structure/function analysis of the interaction of adenomatous polyposis coli with DNA polymerase beta and its implications for base excision repair | Q40052605 | ||
| Uracil incorporation into genomic DNA does not predict toxicity caused by chemotherapeutic inhibition of thymidylate synthase. | Q40066683 | ||
| Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R. | Q40071695 | ||
| Loss of ataxia telangiectasia mutated- and Rad3-related function potentiates the effects of chemotherapeutic drugs on cancer cell survival | Q40146288 | ||
| Mechanism of adenomatous polyposis coli (APC)-mediated blockage of long-patch base excision repair | Q40193968 | ||
| Cigarette smoke condensate-induced level of adenomatous polyposis coli blocks long-patch base excision repair in breast epithelial cells | Q40241112 | ||
| Determination of apoptosis, uracil incorporation, DNA strand breaks, and sister chromatid exchanges under conditions of thymidylate deprivation in a model of BER deficiency | Q40367703 | ||
| Resveratrol-induced apoptotic death in human U251 glioma cells | Q40435921 | ||
| Inactivated MGMT by O6-benzylguanine is associated with prolonged G2/M arrest in cancer cells treated with BCNU. | Q40453300 | ||
| Tumor suppressor APC blocks DNA polymerase beta-dependent strand displacement synthesis during long patch but not short patch base excision repair and increases sensitivity to methylmethane sulfonate | Q40490855 | ||
| Resveratrol and propolis as necrosis or apoptosis inducers in human prostate carcinoma cells | Q40503008 | ||
| Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil. | Q40569604 | ||
| Resveratrol-induced autophagocytosis in ovarian cancer cells | Q40595420 | ||
| The interaction of thymidylate synthase expression with p53-regulated signaling pathways in tumor cells | Q40640303 | ||
| Activation of adenomatous polyposis coli (APC) gene expression by the DNA-alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine requires p53. | Q41072519 | ||
| The chloroethylnitrosoureas: sensitivity and resistance to cancer chemotherapy at the molecular level | Q41669418 | ||
| Formation of cyclic adducts in nucleic acids by the haloethylnitrosoureas | Q42223206 | ||
| Resveratrol induces apoptosis in pancreatic cancer cells. | Q42730841 | ||
| Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients | Q43444041 | ||
| Miscoding properties of 1,N6-ethanoadenine, a DNA adduct derived from reaction with the antitumor agent 1,3-bis(2-chloroethyl)-1-nitrosourea | Q44668728 | ||
| Identification of small molecule synthetic inhibitors of DNA polymerase beta by NMR chemical shift mapping. | Q44982151 | ||
| Resveratrol and quercetin cooperate to induce senescence-like growth arrest in C6 rat glioma cells. | Q45982759 | ||
| AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies | Q46368427 | ||
| Phase II trial of the O6-alkylguanine DNA alkyltransferase inhibitor O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea in advanced melanoma | Q46797243 | ||
| Mammalian abasic site base excision repair. Identification of the reaction sequence and rate-determining steps | Q47724136 | ||
| Quinacrine sensitizes hepatocellular carcinoma cells to TRAIL and chemotherapeutic agents. | Q47984386 | ||
| Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. | Q50711998 | ||
| 5-fluorouracil increases the chemopreventive potentials of resveratrol through DNA damage and MAPK signaling pathway in human colorectal cancer cells. | Q53217998 | ||
| Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: implications for cancer therapy. | Q53590095 | ||
| Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group. | Q54268717 | ||
| Interstrand cross-linking of DNA by 1,3-bis(2-chloroethyl)-1-nitrosourea and other 1-(2-haloethyl)-1-nitrosoureas | Q67562182 | ||
| Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysis | Q72904323 | ||
| Mammalian base excision repair and DNA polymerase beta | Q74754533 | ||
| P433 | issue | 42 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fluorouracil | Q238512 |
| colon cancer | Q18555025 | ||
| P304 | page(s) | 7374-7388 | |
| P577 | publication date | 2013-11-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | 1,3-Bis(2-chloroethyl)-1-nitrosourea enhances the inhibitory effect of resveratrol on 5-fluorouracil sensitive/resistant colon cancer cells | |
| P478 | volume | 19 |
| Q38621653 | Annexin A2 could enhance multidrug resistance by regulating NF-κB signaling pathway in pediatric neuroblastoma |
| Q41858251 | K9(C4H4FN2O2)2Nd(PW11O39)2·25H2O induces apoptosis in human lung cancer A549 cells |
| Q38858851 | NECTIN-4 increased the 5-FU resistance in colon cancer cells by inducing the PI3K-AKT cascade |
| Q92481989 | RV-59 suppresses cytoplasmic Nrf2-mediated 5-fluorouracil resistance and tumor growth in colorectal cancer |
| Q28067369 | Research progress on chemopreventive effects of phytochemicals on colorectal cancer and their mechanisms |
Search more.